Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Abstract Text:

    jong wook yunJong Wook Yun,seong yong limSeong Yong Lim,gee young suhGee Young Suh,man pyo chungMan Pyo Chung,hojoong kimHojoong Kim,o jung kwonO Jung Kwon,hoon-suk chaHoon-Suk Cha,eun-mi kohEun-Mi Koh,won-jung kohWon-Jung Koh,jong wook yunJong Wook Yun,seong yong limSeong Yong Lim,gee young suhGee Young Suh,man pyo chungMan Pyo Chung,hojoong kimHojoong Kim,o jung kwonO Jung Kwon,hoon-suk chaHoon-Suk Cha,eun-mi kohEun-Mi Koh,won-jung kohWon-Jung Koh,

    Tumor necrosis factor (TNF) is essential for host defense against Mycobacterium tuberculosis, and the risk of reactivation of latent tuberculosis infection (LTBI) increases with anti-TNF therapy. This study estimated the prevalence of LTBI and evaluated the safety and completion rate of short-course therapy with isoniazid plus rifampin for 3 months to treat LTBI in a cohort of Korean arthritis patients before initiating anti-TNF therapy. We retrospectively studied the files of 112 consecutive patients to evaluate LTBI before starting anti-TNF drugs. Screening tests were performed, including a tuberculin skin test and chest radiography. LTBI treatment was indicated in 41 patients (37%). Of these, three patients refused the LTBI treatment. Of the 38 patients who underwent LTBI treatment, 36 (95%) took isoniazid plus rifampin for 3 months. Six patients (16%) showed transient elevations of liver enzymes during the LTBI treatment. Overall, 35 patients (92%) completed the LTBI treatment as planned. In conclusion, LTBI was diagnosed in one-third of Korean arthritis patients before initiating anti-TNF therapy. A high percentage of these patients completed 3 months of LTBI treatment with isoniazid plus rifampin without serious complications.

    Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Publishing Authors By Initials

    jw yunJW Yun,sy limSY Lim,gy suhGY Suh,mp chungMP Chung,h kimH Kim,oj kwonOJ Kwon,hs chaHS Cha,em kohEM Koh,wj kohWJ Koh,jw yunJW Yun,sy limSY Lim,gy suhGY Suh,mp chungMP Chung,h kimH Kim,oj kwonOJ Kwon,hs chaHS Cha,em kohEM Koh,wj kohWJ Koh,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of Korean medical science

    VOLUME: 22

    Page Numbers: 779-83

    Journal Abbreviation: J. Korean Med. Sci.

    ISSN: 1011-8934

    DAY: 5

    MONTH: Oct

    YEAR: 2007

    Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8703518

    Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

    AFFILIATION: Division of Pulmonary and Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

    Country: Korea (South)

    Korea (South) Research PublicationKorea (South) Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Korean Med Sci

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News